Delivery Order SPE2DB20D1109-SPE2DB22FN90V
- Not listed
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $10,633.20, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $14,955.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2022, with a completion date of May 23, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $23,379.24 and a performance period through March 15, 2023. The contract is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award is for the delivery of Otezla 30 mg tablets (60 count) to the Defense Logistics Agency (DLA), a major logistics agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distribution company, for a ceiling value of $34,985.94 over the contract period ending on April 24, 2024. This is a firm-fixed price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $29,847.48 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., as a delivery order under their $999,999,999 Indefinite Delivery Contract (IDC) with the DLA. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a wide range of...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and the award has a ceiling value of $15,530.10. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora,...
- This federal contract award is for the delivery of Otezla 30 mg tablets in quantities of 60 per prescription. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical, which runs through November 2026. This IDC enables the DLA to...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under a Delivery Order valued at $8,213.31. The contract has a completion date of March 3, 2022 and uses a Firm Fixed Price pricing structure. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
- This federal contract award is for the supply of Otezla 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order with a firm-fixed price of $5,608.90 and has an ultimate completion date of December 6, 2023. The award was made without a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $18,519.12 and is awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA, valued up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FN90VDelivery Order
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $15,330.58, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 30, 2022 with a completion date of March 31, 2022. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora, Inc. to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs worldwide. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.3k | 3/30/22 |